Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) posted positive results as revenue rose along with patients — showing the growing demand for psychedelics-centered...
Numinus Updates On New Acquisition’s Integration And Provides Client Financing Options Numinus Wellness Inc. (OTCQX: NUMIF) recently acquired psychedelics...
In collaboration with the Manke Lab at UMass Dartmouth and the Designer Drug Research Unit at the National Institute on Drug Abuse Intramural Research...
Psychedelics are being talked about at major conferences all over the world, including South by SouthWest and Aspen Institute's Ideas Week, signaling a...
Renowned academic journal praises company for development of psychoplastogens The post Delix gets recognized as leading start-up by Nature Biotechnology...
Film screening was followed by audience Q&A session hosted by director The post DOSED 2 screening sells out at Vancouver’s Rio Theatre appeared...
Source: Streetwise Reports 09/12/2022 One biopharma co. is teaming with a much larger pharmaceutical company to develop a fast-dissolving...
From some counties pushing back on access to psilocybin therapy to last minute obstacles to facilitator training programs, Oregon is successfully navigating...
Company claims it will 'disrupt cannabis industry' with its new proprietary technology The post KRTL Biotech to deploy ‘state-of-the-art’ mobile extraction...
Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing...